Table 3.
Comparisons of affected eyes, fellow eyes, and normal control at baseline.
| Characteristics | VDSC (%) | p-value (A vs. N) | p-value (A vs. F) |
|---|---|---|---|
| Whole area (baseline) | 49.05 ± 6.63 | <0.001* | <0.001* |
| Target area (baseline) | 44.18 ± 9.27 | <0.001* | <0.001* |
| Whole area (1 month) | 56.57 ± 5.83 | 0.004* | 0.005* |
| Target area (1 month) | 54.31 ± 9.70 | <0.001* | <0.001* |
| Whole area (3 months) | 56.87 ± 5.75 | 0.007* | 0.010* |
| Target area (3 months) | 55.19 ± 6.46 | <0.001* | <0.001* |
| Fellow eyes | 59.77 ± 3.54 | N/A | N/A |
| Normal eyes | 60.05 ± 4.19 | N/A | N/A |
Values are shown as the mean ± SD.
VDSC, vessel density of superficial choroid; A, affected eyes; F, fellow eyes; N, normal eyes.
p < 0.05 (statistically significant difference).